The long-term use of blockers of the platelet ADP receptor in acute coronary syndromes
De Caterina, R.; Zimarino, M.
Haematologica 86(11 Suppl 2: 25-27
2001
ISSN/ISBN: 0390-6078 PMID: 11926769 Document Number: 528532
Document emailed within 1 workday
Related Documents
White, H.D. 2000: Low-molecular-weight heparin and platelet glycoprotein IIb/IIIa receptor blockade in the treatment of acute coronary syndromes: complementary or competing therapies? Journal of Invasive Cardiology 12 Suppl A: 6aQuinn, M.J.; Moliterno, D.J. 2002: Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes Minerva Cardioangiologica 50(5): 547-553
Oomman, A.; Ramachandran, P.; Shanmugapriya; Subramanian, P.; Nagaraj, B.M.S. 2003: A novel trigger for acute coronary syndromes: the effect of lunar cycles on the incidence and in-hospital prognosis of acute coronary syndromes--a 3-year retrospective study Journal of the Indian Medical Association 101(4): 227-228
Erlikh, A.D. 2018: Relationship Between Degree of Coronary Vascular Bed Involvement and Characteristics of Stenting with Short-Term and Long-Term Outcomes in Patients with Acute Coronary Syndrome (Data of the RECORD-3 Registry) Kardiologiia 5: 5-12
Ghaffari, S.; Separham, A.; Pourafkari, L. 2010: Association of electrocardiographic changes with severity of coronary artery disease and short term outcome in patients with non-ST-segment elevation acute coronary syndromes Saudi Medical Journal 31(4): 400-405
Becker, R.C. 2000: The scientific basis for combined platelet and thrombin-directed pharmacotherapy in acute coronary syndromes Journal of Invasive Cardiology 12 Suppl E: E19
Decalf, V.; Sabbah, L.; Lafont, A.; Danchin, N.; Durand, E. 2007: Gp IIb/IIIa receptor antagonists in acute coronary syndromes with no ST elevation Archives des Maladies du Coeur et des Vaisseaux 100(12): 1006-1012
Varani, E.; Vecchio, S.; Aquilina, M.; Vecchi, G.; Balducelli, M.; Frassineti, V.; Margheri, M. 2016: Left main percutaneous coronary intervention in ACS or stable coronary artery disease: acute and long-term results Minerva Cardioangiologica 64(1): 23-33
Rozenman; Mosseri; Mereuta; Gotsman 1998: Monoclonal Antibodies Against the IIb/IIIa Platelet Receptor to Treat Acute Thrombotic Occlusion of a Coronary Stent Journal of Invasive Cardiology 10(1): 42-44
Cohen, M. 2000: Initial experience with the low-molecular-weight heparin, enoxaparin, in combination with the platelet glycoprotein IIb/IIIa blocker, tirofiban, in patients with non-ST segment elevation acute coronary syndromes Journal of Invasive Cardiology 12 Suppl E: E5
Passoni, F.; Morelli, B.; Seveso, G.; Lazzati, L.; Beria, G.; Del Rosso, G.; D'Urbano, M.; Cafiero, F.; Mariani, G.; De Servi, S. 2002: Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 3(1): 28-33
Kozai, T.; Shimokawa, H.; Fukumoto, Y.; Kobayashi, S.; Owada, M.K.; Kadokami, T.; Ito, A.; Kuwata, K.; Egashira, K.; Shiraishi, T.; Kanaide, H.; Takeshita, A. 1997: Tyrosine kinase inhibitor markedly suppresses the development of coronary lesions induced by long-term treatment with platelet-derived growth factor in pigs in vivo Journal of Cardiovascular Pharmacology 29(4): 536-545
Gum, P.A.; Lincoff, A.M. 2003: Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction International Journal of Clinical Practice 57(1): 43-48
Rettig, G. 1980: Beta receptor blockers in the therapy of coronary disease ZFA. Zeitschrift für Allgemeinmedizin 56(9): 600-605
Simek, S.; Aschermann, M.; Holm, F.; Humhal, J.; Linhart, A.; Psenicka, M.; Golán, L.; Mrázek, V. 2003: Long-term prognosis in patients with acute myocardial infarct and treatment with direct coronary angioplasty Casopis Lekaru Ceskych 142(8): 487-492
Itagane, H.; Haze, K. 1994: Elective percutaneous transluminal coronary angioplasty for angina pectoris: acute outcome and long-term effect Nihon Rinsho. Japanese Journal of Clinical Medicine 52 Suppl (Part 1): 845-850
Wita, K.; Filipecki, A.; Szydło, K.; Turski, M.; Tabor, Z.; Wróbel, W.; Elzbieciak, M.; Lelek, M.ł; Bochenek, T.; Trusz-Gluza, M. 2010: Prediction of long-term outcome after primary percutaneous coronary intervention for acute anterior myocardial infarction Kardiologia Polska 68(4): 393-400
Walter, T.; Szabo, S.; Kazmaier, S.; Suselbeck, T.; Götz Nowak; Borggrefe, M.; Hoffmeister, H.M.; Dempfle, C.E. 2011: Investigation of Platelet Adhesiveness in Patients With Coronary Artery Disease and Acute Myocardial Infarction Using the Platelet Adhesion Assay (PADA) Clinical Laboratory 57(5-6): 315-320
Topol, E.J.; Ferguson, J.J.; Weisman, H.F.; Tcheng, J.E.; Ellis, S.G.; Kleiman, N.S.; Ivanhoe, R.J.; Wang, A.L.; Miller, D.P.; Anderson, K.M.; Califf, R.M. 1997: Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication JAMA 278(6): 479-484
Mori, T.; Nosaka, H.; Kimura, T.; Nobuyoshi, M. 1991: Long-term follow-up of patients treated with intracoronary thrombolysis or percutaneous transluminal coronary angioplasty for acute myocardial infarction Journal of Cardiology 21(2): 323-336